SCHEMBL5337977

SCHEMBL5337977

CC(C)(C)OC(=O)c1cccc(C(=O)CN)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.55
LOXL2 Q9Y4K0 1/20 0.44
STAT3 P40763 1/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ACHE P22303 1/20 0.41
ALOX15 P16050 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
ABCB1 P08183 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
F2 P00734 4/20 0.38
TMPRSS6 Q8IU80 2/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110296 0.86 SLC7A5 (0.58) SLC7A5LOXL2STAT3CA12CA1
Water SCHEMBL28897664 0.84 SLC7A5 (0.56) SLC7A5LOXL2STAT3CA12CA1
SCHEMBL28350987 0.84 SLC7A5 (0.56) SLC7A5LOXL2STAT3CA12CA1
Hydrogen Peroxide SCHEMBL27146001 0.84 SLC7A5 (0.60) SLC7A5LOXL2STAT3CA12CA1
SCHEMBL27497505 0.84 SLC7A5 (0.55) SLC7A5LOXL2STAT3CA12CA1
SCHEMBL21015802 0.81 SLC7A5 (0.55) SLC7A5STAT3CA12CA1CA2
SCHEMBL27408427 0.81 SLC7A5 (0.55) SLC7A5LOXL2STAT3CA12CA1
SCHEMBL1505425 0.81 LOXL2 (0.65) SLC7A5LOXL2CA12CA1CA2
SCHEMBL27655813 0.81 SLC7A5 (0.52) SLC7A5LOXL2STAT3CA12CA1
SCHEMBL4928282 0.81 LOXL2 (0.69) SLC7A5LOXL2STAT3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205291-B2 High mouth absorption; antibiotics against gramnegative, grampositive bacteria espscially Staphlococcus pneumonia, Hemophilus influenza DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-04-17 US disclosed
US-20050020566-A1 Novel carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-01-27 US disclosed
EP-1443047-A1 NOVEL CARBAPENEM COMPOUNDS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020566-A1 Novel carbapenem compounds HPN, PRSS1, BPGM SLC7A5 122/4885LOXL2 4128/4885STAT3 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.